CollPlant Biotechnologies Ltd cotiza a 3.91 USD y tiene una capitalización bursátil de $7M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is prod…
| Periodo | 2026-11 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | — | $-2.50 | $-2.70 | $-2.80 |
| Estimado | $-0.50 | $-1.90 | $1.55 | $-1.00 |
| Sorpresa | — | -31.6% | -274.2% | -180.0% |
| Métrica | CLGN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 64.8% | 57.0% | +7.7% |
| Operating Margin | -484.3% | -38.6% | -445.7% |
| Net Margin | -484.6% | -33.6% | -451.0% |
| FCF Margin | -398.4% | -13.9% | -384.6% |
| ROE | -188.9% | -40.4% | -148.5% |
| ROA | -106.5% | -32.0% | -74.5% |
| Current Ratio | 2.53 | 2.84 | -0.31 |
| Debt / Equity | — | 0.28 | — |